Ligand profile
ZINC22054134
Virtual-screening candidate from ZINC.
Bound to: KP13_05032 — Methylated-DNA--protein-cysteine methyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC22054134- UniProt (similar protein)
E5BBQ0- Tanimoto
- 0.723
- Target protein
- KP13_05032
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 94.0
- −1 ≤ LogP ≤ 5 3.70
- MW ≤ 500 Da 431.5
- LogP ≤ 5 3.70
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 94.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CN(C)c1ccc2c(-c3cc(C(=O)O)ccc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1CN(C)c1ccc2c(-c3cc(C(=O)O)ccc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1
InChI=1S/C25H22N2O5/c1-26(2)15-6-9-18-21(12-15)32-22-13-16(27(3)4)7-10-19(22)23(18)20-11-14(24(28)29)5-8-17(20)25(30)31/h5-13H,1-4H3,(H-,28,29,30,31)/p+1InChI=1S/C25H22N2O5/c1-26(2)15-6-9-18-21(12-15)32-22-13-16(27(3)4)7-10-19(22)23(18)20-11-14(24(28)29)5-8-17(20)25(30)31/h5-13H,1-4H3,(H-,28,29,30,31)/p+1
COCMHKNAGZHBDZ-UHFFFAOYSA-OCOCMHKNAGZHBDZ-UHFFFAOYSA-O
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- OGQ
- Homolog
- E5BBQ0
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC22054134 →
- ZINC ZINC20 ZINC22054134 →
- UniProt UniProt E5BBQ0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC22054134”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05032.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).